Eagle Ridge Investment Management’s Altimmune ALT Stock Holding History

Eagle Ridge Investment Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,373	Closed	-$106K	–	139
2024 Q1	$106K	Hold	10,373	–	–	0.01%	147
2023 Q4	$117K	Hold	10,373	–	–	0.01%	143
2023 Q3	$27K	Hold	10,373	–	–	﹤0.01%	143
2023 Q2	$36.6K	Hold	10,373	–	–	﹤0.01%	150
2023 Q1	$43.8K	Hold	10,373	–	–	﹤0.01%	157
2022 Q4	$171K	Hold	10,373	–	–	0.02%	150
2022 Q3	$132K	Hold	10,373	–	–	0.02%	147
2022 Q2	$121K	Buy	+10,373	New	+$64K	0.01%	149

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eagle Ridge Investment Management's ALT Position: Q2 2024 in Review

Eagle Ridge Investment Management sold out of Altimmune (ALT) in Q2 2024, closing a stake of 10,373 shares — an estimated $106K sold.

Eagle Ridge Investment Management first reported a position in ALT in Q2 2022 and held it in 8 quarters. The position peaked at $171K in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

Eagle Ridge Investment Management reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
Eagle Ridge Investment Management sold 10,373 Altimmune shares in Q2 2024, an estimated $106K.
Eagle Ridge Investment Management first reported a position in Altimmune in Q2 2022 and held it in 8 quarters.
Eagle Ridge Investment Management's Altimmune position peaked at $171K in Q4 2022.
173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Eagle Ridge Investment Management's 13F filing for Q2 2024, filed 24 Jul 2024.